United Therapeutics Corporation · NASDAQ:UTHR
Mesa Nilda sold 228 United Therapeutics Corporation shares (Form 4)
Traded Sep 14, 2026 · Filed Sep 15, 2026
On Sep 14, 2026, Mesa Nilda (Director) sold 228 United Therapeutics Corporation shares at an average US$505.87 for US$115K, leaving 5,580 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 228 shares
- Price
- US$505.87 average (US$505.79 to US$505.98)
- Value
- US$115K
- Holding after
- 5,580 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | Option exercise | 130 | US$110.86 | 6,560 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 130 | US$505.79 | 6,430 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 98 | US$505.98 | 5,580 | Direct |
Source
Related
- United Therapeutics Corporation
- Mesa Nilda
- United Therapeutics Corporation shareholders
- Form 4 · Mesa Nilda · Jul 13, 2026
- Form 4 · Mesa Nilda · May 13, 2026
- Form 4 · Rothblatt Martine A · Oct 21, 2026
- Form 4 · Rothblatt Martine A · Oct 20, 2026
- Form 4 · Rothblatt Martine A · Oct 19, 2026
- Schedule 13G/A · Rothblatt Martine A · Aug 14, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026